Fanconi Anemia Research Fund Eugene, OR - 97401

Fanconi Anemia Research Fund is categorized under Medical Research in Eugene, OR and active since 1989.

Fanconi Anemia Research Fund was established in 1989, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 8133190 by the NAICS.

If you are seeking more information, feel free to contact Beverley Mayhew, Executive Director at the company’s single location by writing to 1801 Willamette St # 200, Eugene, Oregon OR 97401 or by phoning (541) 687-4658. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Fanconi Anemia Research Fund
Contact Person: Beverley Mayhew, Executive Director
Address: 1801 Willamette St # 200, Eugene, Oregon 97401
Phone Number: (541) 687-4658
Website Address: fanconi.org
Annual Revenue (USD): Unknown
Founded: 1989
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 8133190
Share This Business:

Fanconi Anemia Research Fund was started in 1989 to provide professional Medical Research under the SIC code 8733 and NAICS code 8133190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Beverley Mayhew, Executive Director for inquiries that concern Fanconi Anemia Research Fund by calling the company number (541) 687-4658, as your correspondence is most welcome. Additionally, the physical location of the single location of Fanconi Anemia Research Fund can be found at the coordinates 44.03976,-123.09268 as well as the street address 1801 Willamette St # 200 in Eugene, Oregon 97401.

For its online presence, you may visit Fanconi Anemia Research Fund’s website at fanconi.org and engage with its social media outlets through on Twitter and on Facebook.